http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2012DN03914-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
filingDate 2010-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b3fe4180f1ce4e4fb99c4ed3da12d94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7822c7eb8a927f1ad9738f65c26fb1
publicationDate 2015-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IN-2012DN03914-A
abstract The present invention relates to combinations between artemisinin-based potent anti¬malarial agents, selected from the group consisting of ART, DHA and ARM, and a further chemotherapeutic drug selected from the group consisting of a camptothecin derivative, or a PARP-1 inhibitor, or an intercalating DNA agent, or an alkylating agent. Such combinations, showed medium to strong synergism in various models of cancer, in particular in NSCL.
priorityDate 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98047509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID99929

Total number of triples: 25.